Terabe et al. and Renukaradhya et al. independently conducted experiments employing CD1d knockout and Jα18 knockout mice, and they both demonstrated that CD1d-restricted type II NKT cells downregulated cancer immunosurveillance (51, 52). This evidence concerns the gene CD1D and cancer.